Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gene expression involved in synaptic plasticity refers to the dynamic regulation of genes within neurons that underlies the ability of synapses—the connections between nerve cells—to strengthen or weaken over time. This process is fundamental for learning, memory formation, and adaptive neural circuit function. Key genes include Arc, Egr1, CREB, Gria2/Gria3, and NR2B. Disruption or deregulation of these gene networks is implicated in neurodegenerative diseases such as Alzheimer’s disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gene Expression Involved in Synaptic Plasticity.